Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
211 participants
INTERVENTIONAL
2013-05-31
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that the intervention, instruction in self-referral, will:
* reduce fear of recurrence
* improve quality of life
* improve cost-utility
* not affect disease-free survival.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Follow-up
Patients in this arm attend regular follow-up examinations, as is the current standard, at the department of gynecology following surgery.
No interventions assigned to this group
Self-referral
Instead of regular follow-up examinations, this group is carefully instructed in alarm symptoms that require contact with a physician.
Instruction in self-referral
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Instruction in self-referral
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Illiterate in Danish
* Treated with adjuvant chemo- and/or radiotherapy
* high risk histology
* grade 3
* follow-up for other gynecologic malignancy
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Research Unit of General Practice, Odense
OTHER
University of Southern Denmark
OTHER
Danish Cancer Society
OTHER
Odense University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mette Moustgaard Mathiesen
PhD student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mette M Mathiesen
Role: PRINCIPAL_INVESTIGATOR
Department of Gynecology, Odense University Hospital
Ole Mogensen, Professor
Role: STUDY_CHAIR
Department of Gynecology, Odense University Hospital
Pernille T Jensen, PhD
Role: STUDY_CHAIR
Department of Gynecology, Odense University Hospital
Dorte G Hansen, Lector, PhD
Role: STUDY_CHAIR
Research Unit of General Practice, Odense University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aalborg University Hospital
Aalborg, , Denmark
Research Unit of gynecology, Odense University hospital
Odense C, , Denmark
Roskilde Hospital
Roskilde, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OPAL
Identifier Type: -
Identifier Source: org_study_id